IBM (IBM) Cut at Oppenheimer as Software Growth Delayed

Oppenheimer downgraded IBM (IBM), citing a longer timeline for the company's software growth to materialize. The firm raised its price target for IBM to $145, while previously it had anticipated more immediate gains. Investors should note this change, as it may impact trader sentiment and expectations concerning IBM's near-term performance. The analysis indicates that while there are potential gains, the path to realizing them is extended, which can influence market dynamics.